Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations

OBJECTIVE: To investigate the clinical features of patients with non-small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor (EGFR) mutations, and the treatment outcomes of EGFR tyrosine kinase inhibitors (TKIs) in these patients. METHODS: We retrospectively analyzed the d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Chin J Cancer Res
Auteurs principaux: Zhang, Yan, Wang, Zheng, Hao, Xuezhi, Hu, Xingsheng, Wang, Hongyu, Wang, Yan, Ying, Jianming
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5348472/
https://ncbi.nlm.nih.gov/pubmed/28373750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.03
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires